| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial
|
Clarke, Jeffrey M.
|
|
|
3 |
6 |
p.
|
artikel
|
| 2 |
Automating Access to Real-World Evidence
|
Gauthier, Marie-Pier
|
|
|
3 |
6 |
p.
|
artikel
|
| 3 |
Biomarker Testing for Patients With Advanced/Metastatic Nonsquamous NSCLC in the United States of America, 2015 to 2021
|
Hess, Lisa M.
|
|
|
3 |
6 |
p.
|
artikel
|
| 4 |
Brief Report on Teleconsultation in Lung Cancer: Toward a Semiotic Paradigm Shift?
|
Thomas, Quentin Dominique
|
|
|
3 |
6 |
p.
|
artikel
|
| 5 |
Functional Trajectories and Resilience Among Adults With Advanced Lung Cancer
|
Presley, Carolyn J.
|
|
|
3 |
6 |
p.
|
artikel
|
| 6 |
Genomic and Transcriptomic Analysis of Neuroendocrine Transformation in ALK-Rearranged Lung Adenocarcinoma After Treatments With Sequential ALK Inhibitors: A Brief Report
|
Huang, Jie
|
|
|
3 |
6 |
p.
|
artikel
|
| 7 |
High-Dose Osimertinib for CNS Progression in EGFR+ NSCLC: A Multi-Institutional Experience
|
Piper-Vallillo, A.J.
|
|
|
3 |
6 |
p.
|
artikel
|
| 8 |
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report
|
Chen, Yuanbin
|
|
|
3 |
6 |
p.
|
artikel
|
| 9 |
Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC
|
Drilon, Alexander
|
|
|
3 |
6 |
p.
|
artikel
|
| 10 |
Percutaneous Image-Guided Biopsy for a Comprehensive Hybridization Capture-Based Next-Generation Sequencing in Primary Lung Cancer: Safety, Efficacy, and Predictors of Outcome
|
Elsakka, Ahmed
|
|
|
3 |
6 |
p.
|
artikel
|
| 11 |
Response to Pralsetinib Observed in Meningeal-Metastatic EGFR-Mutant NSCLC With Acquired RET Fusion: A Brief Report
|
Zhao, Zichen
|
|
|
3 |
6 |
p.
|
artikel
|
| 12 |
Severe Pulmonary Toxicity With Concurrent Anlotinib and Chemoradiotherapy in Stage III NSCLC: The ALTER-L042 Phase 1 Clinical Trial
|
Zhu, Hui
|
|
|
3 |
6 |
p.
|
artikel
|
Tijdschrift beschrijving